Alnylam Pharmaceuticals (ALNY) Shares Issued (2010 - 2018)
Alnylam Pharmaceuticals' (ALNY) quarterly Shares Issued came in at $9.8 million in Q4 2018, up 8.0% YoY from $9.1 million in Q4 2017, and up 8.0% on a QoQ basis from $9.1 million in Q4 2017.
Alnylam Pharmaceuticals (ALNY) Shares Issued (2010 - 2018) Analysis & Trends
Alnylam Pharmaceuticals (ALNY) has 9 years of Shares Issued data on file, last reported at $9.8 million in Q4 2018.
- Quarterly Shares Issued rose 8.0% year-over-year to $9.8 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $9.8 million (up 8.0% YoY) and the FY2018 annual result came in at $9.8 million, up 8.0% from the prior year.
- Shares Issued advanced to $9.8 million in Q4 2018, from $9.1 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $9.9 million in Q4 2016 to a low of $7.5 million in Q4 2014.
- A 5-year average of $8.9 million and a median of $9.1 million in 2017 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2014 — Shares Issued dropped 8.67% — and 2016, when it advanced 19.18%.
- Tracing ALNY's Shares Issued over 5 years: stood at $7.5 million in 2014, then advanced by 10.46% to $8.3 million in 2015, then grew by 19.18% to $9.9 million in 2016, then dropped by 8.19% to $9.1 million in 2017, then rose by 8.0% to $9.8 million in 2018.
- The last three Shares Issued figures came in at $9.8 million (Q4 2018), $9.1 million (Q4 2017), and $9.9 million (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.42 Mn |
| Dec 31, 2018 | 1.42 Mn |
| Dec 31, 2017 | 9.10 Mn |
| Dec 31, 2017 | 9.10 Mn |
| Dec 31, 2016 | 2.36 Mn |
| Dec 31, 2016 | 2.36 Mn |
| Dec 31, 2015 | 1.64 Mn |
| Dec 31, 2015 | 1.64 Mn |
| Dec 31, 2014 | 639,000.00 |
| Dec 31, 2014 | 639,000.00 |
| Dec 31, 2013 | 8.25 Mn |
| Dec 31, 2013 | 8.25 Mn |
| Dec 31, 2012 | 8.93 Mn |
| Dec 31, 2012 | 8.93 Mn |
| Dec 31, 2011 | 6.03 Mn |
| Dec 31, 2011 | 6.03 Mn |
| Dec 31, 2010 | 4.98 Mn |
| Dec 31, 2010 | 4.98 Mn |